The Ensign Group, Inc. (ENSG) Analyse boursière

Présentation de l'entreprise

The Ensign Group, Inc. (ENSG) delivers a comprehensive portfolio of healthcare solutions encompassing skilled nursing, senior living, and rehabilitative services to patients across the United States. This entity operates within the broader Healthcare sector, specifically targeting the Medical Care Facilities industry, a segment defined by the provision of essential clinical and supportive care for diverse patient populations. The company's operational scale is substantial, with a market capitalization of $11.96B and an annual revenue base of $5.06B, supported by a workforce of 46,000 employees. These valuation and revenue figures indicate that ENSG holds a significant position within its niche, reflecting a large market presence and the ability to generate substantial economic output through its two primary segments: Skilled Services and Standard Bearer.

Santé financière

The company reports a trailing twelve-month (TTM) revenue of $5.06B, generating a net income of $343.97M and an EBITDA of $528.67M. The substantial gap between the $5.06B revenue and the $343.97M net income highlights a cost structure where operating expenses, including cost of goods sold and general administrative costs, consume approximately 93% of total top-line revenue before interest and taxes. The free cash flow stands at $281.25M, which provides the organization with significant financial flexibility to fund capital expenditures, manage working capital needs, or pursue strategic acquisitions without immediate reliance on external financing. Analysis of the three key margins reveals a gross margin of 16.3%, indicating the company's efficiency in producing its core services relative to direct costs. An operating margin of 9.1% reflects the effectiveness of management in controlling overhead expenses, while a profit margin of 6.8% demonstrates the final profitability after all expenses, interest, and taxes are deducted. On the balance sheet, the company holds $572.39M in cash against total debt of $2.21B, resulting in a debt-to-equity ratio of 98.70%, which suggests a leveraged capital structure where debt obligations nearly equal the book value of equity. The current ratio of 1.42 indicates that the company possesses sufficient current assets to cover its short-term liabilities, suggesting a comfortable level of short-term liquidity. Return on Equity (ROE) is reported at 16.9%, while Return on Assets (ROA) is 5.2%, metrics that reveal management's effectiveness in generating returns for shareholders relative to the equity invested and the total asset base utilized.

Évaluation de la valorisation

The valuation metrics for The Ensign Group, Inc. show a trailing P/E ratio of 35.07 compared to a forward P/E of 24.86. The notable difference between the trailing P/E of 35.07 and the forward P/E of 24.86 implies that the market expects earnings growth in the future that would significantly compress the current valuation multiple over the coming year. The price-to-book ratio is 5.29, indicating that the stock trades at a substantial premium over its book value, suggesting the market values the company's intangible assets, such as its skilled nursing network and brand reputation, highly above its tangible asset base. Alternative valuation metrics include a price-to-sales ratio of 2.37 and an EV/EBITDA of 25.44, which suggest the company is valued at a premium relative to its sales and earnings power compared to traditional benchmarks. The stock's recent price range is defined by a 52-week high of $218.00 and a 52-week low of $118.73. Without the current share price provided in the source facts, the specific percentage distance from the high cannot be calculated, but the wide range between $118.73 and $218.00 demonstrates significant intraperiod volatility. The beta value of 0.82 indicates that the stock's price volatility is lower than the broader market, moving roughly 18% less than the market average during periods of systemic risk or rally.

Growth & Income

The company demonstrates robust expansion with a revenue growth rate of 20.2% year-over-year and an earnings growth rate of 18.4% year-over-year. The fact that earnings growth of 18.4% is slightly slower than revenue growth of 20.2% implies that the company may be experiencing margin compression or increased operating costs that are absorbing a portion of the top-line gains. As a dividend payer, the company offers a dividend yield of 0.1% with a payout ratio of 4.3%. This extremely low payout ratio indicates that the company retains the vast majority of its earnings for reinvestment into the business rather than distributing them to shareholders, which aligns with its growth strategy. The combination of double-digit revenue growth, accelerating earnings expansion, and a minimal dividend payout illustrates a growth-oriented profile where capital is prioritized for scaling operations and market share acquisition.